{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:23:46Z","timestamp":1778909026377,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) to P.B. and A.K.","award":["GCUGR1125641042D"],"award-info":[{"award-number":["GCUGR1125641042D"]}]},{"name":"The 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund) to P.B. and A.K.","award":["GCUGR1125641042D"],"award-info":[{"award-number":["GCUGR1125641042D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pimobendan has been proven to delay the onset of congestive heart failure (CHF) in dogs with mitral regurgitation (MR); however, molecular underlying mechanisms have not been fully elucidated. This study aimed to investigate (1) the effects of pimobendan on cardiac function, cardiac mitochondrial quality and morphology, and cardiac ultrastructure in a rat model of chronic MR and (2) the direct effect of pimobendan on intracellular reactive oxygen species (ROS) production in cardiac cells. MR was surgically induced in 20 Sprague-Dawley rats, and sham procedures were performed on 10 rats. Eight weeks post-surgery, the MR rats were randomly divided into two groups: the MR group and the MR\u2009+\u2009pimobendan group. Pimobendan (0.15\u00a0mg\/kg) was administered twice a day via oral gavage for 4 weeks, whereas the sham and MR groups received equivalent volumes of drinking water. Echocardiography was performed at baseline (8 weeks post-surgery) and at the end of the study (4 weeks after treatment). At the end of the study protocol, all rats were euthanized, and their hearts were immediately collected, weighed, and used for transmission electron microscopy and mitochondrial quality assessments. To evaluate the role of pimobendan on intracellular ROS production, preventive or scavenging properties were tested with H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-induced ROS generation in rat cardiac myoblasts (H9c2).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Pimobendan preserved cardiac functions and structure in MR rats. In addition, pimobendan significantly improved mitochondrial quality by attenuating ROS production and depolarization (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The cardiac ultrastructure and mitochondrial morphology were significantly preserved in the MR\u2009+\u2009pimobendan group. In addition, pimobendan appeared to play as a ROS scavenger, but not as a ROS preventer, in H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-induced ROS production in H9c2 cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Pimobendan demonstrated cardioprotective effects on cardiac function and ultrastructure by preserving mitochondrial quality and acted as an ROS scavenger in a rat model of MR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-023-03693-2","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T04:02:06Z","timestamp":1692763326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation"],"prefix":"10.1186","volume":"19","author":[{"given":"Pakit","family":"Boonpala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakkawee","family":"Saengklub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirinapa","family":"Srikam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilawan","family":"Ji-au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowalak","family":"Panyasing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarawut","family":"Kumphune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusak","family":"Kijtawornrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"issue":"3","key":"3693_CR1","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Keene","year":"2019","unstructured":"Keene BW, Atkins CE, Bonagura JD, Fox PR, Haggstrom J, Fuentes VL, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33(3):1127\u201340.","journal-title":"J Vet Intern Med"},{"issue":"22","key":"3693_CR2","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.107.755942","volume":"118","author":"WH Gaasch","year":"2008","unstructured":"Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008;118(22):2298\u2013303.","journal-title":"Circulation"},{"issue":"6","key":"3693_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jvim.14586","volume":"30","author":"A Boswood","year":"2016","unstructured":"Boswood A, Haggstrom J, Gordon SG, Wess G, Stepien RL, Oyama MA, et al. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: the EPIC Study-A Randomized Clinical Trial. J Vet Intern Med. 2016;30(6):1765\u201379.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"3693_CR4","first-page":"255","volume":"16","author":"VL Fuentes","year":"2002","unstructured":"Fuentes VL, Corcoran B, French A, Schober KE, Kleemann R, Justus C. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. J Vet Intern Med. 2002;16(3):255\u201361.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"3693_CR5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1939-1676.2008.0116.x","volume":"22","author":"MR O\u2019Grady","year":"2008","unstructured":"O\u2019Grady MR, Minors SL, O\u2019Sullivan ML, Horne R. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy. J Vet Intern Med. 2008;22(4):897\u2013904.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"3693_CR6","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/jvim.15863","volume":"34","author":"G Wess","year":"2020","unstructured":"Wess G, Kresken JG, Wendt R, Gaugele J, Killich M, Keller L, et al. Efficacy of adding ramipril (VAsotop) to the combination of furosemide (lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: the VALVE trial. J Vet Intern Med. 2020;34(6):2232\u201341.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"3693_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.fjc.0000432861.55968.a6","volume":"63","author":"AA Knowlton","year":"2014","unstructured":"Knowlton AA, Chen L, Malik ZA. Heart failure and mitochondrial dysfunction: the role of mitochondrial fission\/fusion abnormalities and new therapeutic strategies. J Cardiovasc Pharmacol. 2014;63(3):196\u2013206.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"3693_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21(1):103\u201315.","journal-title":"Cell Res"},{"issue":"2","key":"3693_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/CIRCRESAHA.111.300496","volume":"112","author":"SF Steinberg","year":"2013","unstructured":"Steinberg SF. Oxidative stress and sarcomeric proteins. Circ Res. 2013;112(2):393\u2013405.","journal-title":"Circ Res"},{"issue":"5","key":"3693_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/hh1701.096615","volume":"89","author":"DR Pimentel","year":"2001","unstructured":"Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res. 2001;89(5):453\u201360.","journal-title":"Circ Res"},{"issue":"6","key":"3693_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11906-010-0149-8","volume":"12","author":"M Bayeva","year":"2010","unstructured":"Bayeva M, Ardehali H. Mitochondrial dysfunction and oxidative damage to sarcomeric proteins. Curr Hypertens Rep. 2010;12(6):426\u201332.","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"3693_CR12","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1172\/JCI118280","volume":"96","author":"W Cheng","year":"1995","unstructured":"Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, et al. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96(5):2247\u201359.","journal-title":"J Clin Invest"},{"issue":"3","key":"3693_CR13","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1529\/biophysj.104.041749","volume":"87","author":"S Cortassa","year":"2004","unstructured":"Cortassa S, Aon MA, Winslow RL, O\u2019Rourke B. A mitochondrial oscillator dependent on reactive oxygen species. Biophys J. 2004;87(3):2060\u201373.","journal-title":"Biophys J"},{"issue":"2","key":"3693_CR14","first-page":"151","volume":"11","author":"SC Chattipakorn","year":"2014","unstructured":"Chattipakorn SC, Thummasorn S, Sanit J, Chattipakorn N. Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart. J Geriatr Cardiol. 2014;11(2):151\u20137.","journal-title":"J Geriatr Cardiol"},{"key":"3693_CR15","doi-asserted-by":"crossref","unstructured":"Schenkl C, Heyne E, Doenst T, Schulze PC, Nguyen TD. Targeting mitochondrial metabolism to save the failing heart. Life (Basel). 2023;13(4).","DOI":"10.3390\/life13041027"},{"key":"3693_CR16","doi-asserted-by":"publisher","first-page":"646437","DOI":"10.3389\/fvets.2021.646437","volume":"8","author":"K Abbott-Johnson","year":"2021","unstructured":"Abbott-Johnson K, Pierce KV, Roof S, Del Rio CL, Hamlin R. Acute Effects of Pimobendan on Cardiac function in Dogs with Tachycardia Induced Dilated Cardiomyopathy: a randomized, Placebo-Controlled, crossover study. Front Vet Sci. 2021;8:646437.","journal-title":"Front Vet Sci"},{"issue":"6","key":"3693_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00005344-200006000-00011","volume":"35","author":"R Ishiki","year":"2000","unstructured":"Ishiki R, Ishihara T, Izawa H, Nagata K, Hirai M, Yokota M. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure. J Cardiovasc Pharmacol. 2000;35(6):897\u2013905.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3693_CR18","doi-asserted-by":"publisher","first-page":"656902","DOI":"10.3389\/fvets.2021.656902","volume":"8","author":"P Pichayapaiboon","year":"2021","unstructured":"Pichayapaiboon P, Tantisuwat L, Boonpala P, Saengklub N, Boonyarattanasoonthorn T, Khemawoot P, et al. Pharmacodynamics and pharmacokinetics of Injectable Pimobendan and its metabolite, O-Desmethyl-Pimobendan, in healthy dogs. Front Vet Sci. 2021;8:656902.","journal-title":"Front Vet Sci"},{"issue":"10","key":"3693_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4070\/kcj.2011.41.10.603","volume":"41","author":"KH Kim","year":"2011","unstructured":"Kim KH, Kim YJ, Lee SP, Kim HK, Seo JW, Sohn DW, et al. Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis. Korean Circ J. 2011;41(10):603\u201311.","journal-title":"Korean Circ J"},{"key":"3693_CR20","doi-asserted-by":"publisher","first-page":"121929","DOI":"10.1016\/j.lfs.2023.121929","volume":"328","author":"P Jungtanasomboon","year":"2023","unstructured":"Jungtanasomboon P, Nussaro S, Winwan H, Suebthawinkul P, Boonpala P, Dong VNK, et al. Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation. Life Sci. 2023;328:121929.","journal-title":"Life Science"},{"issue":"1","key":"3693_CR21","doi-asserted-by":"publisher","first-page":"11472","DOI":"10.1038\/s41598-023-38694-6","volume":"13","author":"L Tantisuwat","year":"2023","unstructured":"Tantisuwat L, Saengklub N, Boonpala P, Kumphune S, Panyasing Y, Kalandakanond-Thongsong S, et al. Sacubitril\/valsartan mitigates cardiac remodeling, systolic dysfunction, and preserves mitochondrial quality in a rat model of mitral regurgitation. Sci Rep. 2023;13(1):11472.","journal-title":"Sci Rep."},{"issue":"4","key":"3693_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2460\/ajvr.21.03.0032","volume":"83","author":"SM Ozawa","year":"2022","unstructured":"Ozawa SM, Guzman DS, Hawkins MG, Diao SM, Masri AE, Gunther-Harrington CT, et al. Pharmacokinetics of pimobendan following oral administration to New Zealand White rabbits (Oryctolagus cuniculus). Am J Vet Res. 2022;83(4):356\u201363.","journal-title":"Am J Vet Res"},{"issue":"4","key":"3693_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jvc.2016.07.001","volume":"18","author":"M Yata","year":"2016","unstructured":"Yata M, McLachlan AJ, Foster DJ, Hanzlicek AS, Beijerink NJ. Single-dose pharmacokinetics and cardiovascular effects of oral pimobendan in healthy cats. J Vet Cardiol. 2016;18(4):310\u201325.","journal-title":"J Vet Cardiol"},{"issue":"5","key":"3693_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/A:1013385305567","volume":"15","author":"M Endoh","year":"2001","unstructured":"Endoh M. Mechanism of action of Ca2 + sensitizers\u2013update 2001. Cardiovasc Drugs Ther. 2001;15(5):397\u2013403.","journal-title":"Cardiovasc Drugs Ther"},{"key":"3693_CR25","doi-asserted-by":"crossref","unstructured":"Saengklub N, Boonyarattanasoonthorn T, Kijtawornrat A, Chantasart D. Preliminary bioequivalence of an oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs. Vet Sci. 2022;9(3).","DOI":"10.3390\/vetsci9030141"},{"issue":"4","key":"3693_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jcmg.2018.01.009","volume":"11","author":"A El Sabbagh","year":"2018","unstructured":"El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging. 2018;11(4):628\u201343.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"3693_CR27","first-page":"502","volume":"104","author":"JR Reis Filho","year":"2015","unstructured":"Reis Filho JR, Cardoso JN, Cardoso CM, Pereira-Barretto AC. Reverse cardiac remodeling: a marker of Better Prognosis in Heart failure. Arq Bras Cardiol. 2015;104(6):502\u20136.","journal-title":"Arq Bras Cardiol"},{"key":"3693_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jvc.2022.12.002","volume":"45","author":"RE Ellis-Reis","year":"2023","unstructured":"Ellis-Reis RE, Visser LC, Hsue W, Sharpe AN, Kaplan JL. Echocardiographic evaluation of regurgitant fraction in dogs with subclinical myxomatous mitral valve disease: Method comparison, effects of pimobendan, and reproducibility. J Vet Cardiol. 2023;45:27\u201340.","journal-title":"J Vet Cardiol"},{"issue":"11","key":"3693_CR29","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.freeradbiomed.2011.08.022","volume":"51","author":"JD Gladden","year":"2011","unstructured":"Gladden JD, Zelickson BR, Wei CC, Ulasova E, Zheng J, Ahmed MI, et al. Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload. Free Radic Biol Med. 2011;51(11):1975\u201384.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3693_CR30","doi-asserted-by":"publisher","first-page":"H32","DOI":"10.1152\/ajpheart.00027.2017","volume":"313","author":"JL Guichard","year":"2017","unstructured":"Guichard JL, Rogowski M, Agnetti G, Fu L, Powell P, Wei CC, et al. Desmin loss and mitochondrial damage precede left ventricular systolic failure in volume overload heart failure. Am J Physiol Heart Circ Physiol. 2017;313(1):H32\u2013H45.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"3693_CR31","doi-asserted-by":"publisher","first-page":"H651","DOI":"10.1152\/ajpheart.00638.2014","volume":"308","author":"DM Yancey","year":"2015","unstructured":"Yancey DM, Guichard JL, Ahmed MI, Zhou L, Murphy MP, Johnson MS, et al. Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload. Am J Physiol Heart Circ Physiol. 2015;308(6):H651\u201363.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt 2","key":"3693_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(Pt 2):335\u201344.","journal-title":"J Physiol"},{"issue":"6","key":"3693_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0898-6568(01)00273-X","volume":"14","author":"JA Rosado","year":"2002","unstructured":"Rosado JA, Gonzalez A, Salido GM, Pariente JA. Effects of reactive oxygen species on actin filament polymerisation and amylase secretion in mouse pancreatic acinar cells. Cell Signal. 2002;14(6):547\u201356.","journal-title":"Cell Signal"},{"issue":"7","key":"3693_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jacc.2009.08.074","volume":"55","author":"MI Ahmed","year":"2010","unstructured":"Ahmed MI, Gladden JD, Litovsky SH, Lloyd SG, Gupta H, Inusah S, et al. Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction > 60%. J Am Coll Cardiol. 2010;55(7):671\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3693_CR35","doi-asserted-by":"publisher","first-page":"H2251","DOI":"10.1152\/ajpheart.01104.2010","volume":"300","author":"YW Chen","year":"2011","unstructured":"Chen YW, Pat B, Gladden JD, Zheng J, Powell P, Wei CC, et al. Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. Am J Physiol Heart Circ Physiol. 2011;300(6):H2251\u201360.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"3693_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00005344-199910000-00004","volume":"34","author":"J Cone","year":"1999","unstructured":"Cone J, Wang S, Tandon N, Fong M, Sun B, Sakurai K, et al. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol. 1999;34(4):497\u2013504.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"3693_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1124\/jpet.108.136218","volume":"326","author":"M Fukasawa","year":"2008","unstructured":"Fukasawa M, Nishida H, Sato T, Miyazaki M, Nakaya H. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts. J Pharmacol Exp Ther. 2008;326(1):100\u20134.","journal-title":"J Pharmacol Exp Ther"},{"key":"3693_CR38","doi-asserted-by":"publisher","first-page":"714774","DOI":"10.3389\/fcvm.2021.714774","volume":"8","author":"D Corporan","year":"2021","unstructured":"Corporan D, Segura A, Padala M. Ultrastructural adaptation of the cardiomyocyte to chronic mitral regurgitation. Front Cardiovasc Med. 2021;8:714774.","journal-title":"Front Cardiovasc Med"},{"issue":"22","key":"3693_CR39","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.119.043939","volume":"141","author":"S Li","year":"2020","unstructured":"Li S, Nguyen NUN, Xiao F, Menendez-Montes I, Nakada Y, Tan WLW, et al. Mechanism of eccentric cardiomyocyte hypertrophy secondary to severe mitral regurgitation. Circulation. 2020;141(22):1787\u201399.","journal-title":"Circulation"},{"issue":"2","key":"3693_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/MAJ.0b013e318224ab93","volume":"342","author":"JD Gladden","year":"2011","unstructured":"Gladden JD, Ahmed MI, Litovsky SH, Schiros CG, Lloyd SG, Gupta H, et al. Oxidative stress and myocardial remodeling in chronic mitral regurgitation. Am J Med Sci. 2011;342(2):114\u20139.","journal-title":"Am J Med Sci"},{"issue":"2","key":"3693_CR41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/jmcc.1996.0035","volume":"28","author":"K Prasad","year":"1996","unstructured":"Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol. 1996;28(2):375\u201385.","journal-title":"J Mol Cell Cardiol"},{"key":"3693_CR42","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council. Guide for the care and use of laboratory animals. 8th ed. Washington D.C.: National Academies Press; 2011.","edition":"8"},{"issue":"3","key":"3693_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/FJC.0000000000000652","volume":"73","author":"TM Nakata","year":"2019","unstructured":"Nakata TM, Suzuki K, Uemura A, Shimada K, Tanaka R. Contrasting Effects of Inhibition of phosphodiesterase 3 and 5 on cardiac function and interstitial fibrosis in rats with Isoproterenol-Induced Cardiac Dysfunction. J Cardiovasc Pharmacol. 2019;73(3):195\u2013205.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"3693_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of Echocardiography Committee on Standards, Subcommittee on quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358\u201367.","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"3693_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00395-003-0401-3","volume":"98","author":"T Reffelmann","year":"2003","unstructured":"Reffelmann T, Kloner RA. Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol. 2003;98(5):275\u201384.","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"3693_CR46","first-page":"e22941","volume":"3","author":"A Darbandi Azar","year":"2014","unstructured":"Darbandi Azar A, Tavakoli F, Moladoust H, Zare A, Sadeghpour A. Echocardiographic evaluation of cardiac function in ischemic rats: value of m-mode echocardiography. Res Cardiovasc Med. 2014;3(4):e22941.","journal-title":"Res Cardiovasc Med"},{"issue":"4","key":"3693_CR47","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1292\/jvms.16-0372","volume":"79","author":"A Kijtawornrat","year":"2017","unstructured":"Kijtawornrat A, Komolvanich S, Saengklub N, Pirintr P, Boonpala P, Buranakarl C. Long-term effect of sildenafil on echocardiographic parameters in dogs with asymptomatic myxomatous mitral valve degeneration. J Vet Med Sci. 2017;79(4):788\u201394.","journal-title":"J Vet Med Sci"},{"issue":"12","key":"3693_CR48","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3109\/13880209.2015.1014569","volume":"53","author":"S Kumphune","year":"2015","unstructured":"Kumphune S, Surinkaew S, Chattipakorn SC, Chattipakorn N. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia\/reperfusion injury. Pharm Biol. 2015;53(12):1831\u201341.","journal-title":"Pharm Biol"},{"issue":"3","key":"3693_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.mito.2011.01.008","volume":"11","author":"S Thummasorn","year":"2011","unstructured":"Thummasorn S, Kumfu S, Chattipakorn S, Chattipakorn N. Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion. 2011;11(3):457\u201366.","journal-title":"Mitochondrion"},{"key":"3693_CR50","doi-asserted-by":"crossref","unstructured":"Sivandzade F, Bhalerao A, Cucullo L. Analysis of the mitochondrial membrane potential using the Cationic JC-1 dye as a sensitive fluorescent probe. Bio Protoc. 2019;9(1).","DOI":"10.21769\/BioProtoc.3128"},{"issue":"3","key":"3693_CR51","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1210\/endo.139.3.5771","volume":"139","author":"S Fujimoto","year":"1998","unstructured":"Fujimoto S, Ishida H, Kato S, Okamoto Y, Tsuji K, Mizuno N, et al. The novel insulinotropic mechanism of pimobendan: direct enhancement of the exocytotic process of insulin secretory granules by increased Ca2+ sensitivity in beta-cells. Endocrinology. 1998;139(3):1133\u201340.","journal-title":"Endocrinology"},{"issue":"1","key":"3693_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/bmc-2018-0004","volume":"9","author":"E Prompunt","year":"2018","unstructured":"Prompunt E, Nernpermpisooth N, Sanit J, Kumphune S. Overexpression and pre-treatment of recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduces an in vitro ischemia\/reperfusion injury in rat cardiac myoblast (H9c2) cell. Biomol Concepts. 2018;9(1):17\u201332.","journal-title":"Biomol Concepts"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03693-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:19:43Z","timestamp":1700410783000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03693-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3693"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03693-2","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of Chulalongkorn University Laboratory Animal Center (Animal Use Protocol No. 1873022). All experimental procedures in animals were performed in accordance with the Guide for the Care and Use of Laboratory Animals [] and Animal Welfare Act 2015. All reported methods are in accordance with the ARRIVE 2.0 guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}